News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
Presentation AHA 2024 Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial Presenter: Sanjit S Jolly November 17, 2024
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News AHA 2020 OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP Shelley Wood November 14, 2020
News Conference News AHA 2020 Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS Michael O'Riordan November 14, 2020
News Conference News AHA 2020 Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol Michael O'Riordan November 12, 2020
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Conference News AHA 2015 Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower Yael L. Maxwell November 08, 2015
News Conference News AHA 2014 Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Long-Term Better than Short-Term Prasugrel After PES Stenting November 15, 2014
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011